“... related to ocean temperature and initial carbon content, with higher rates of biomass loss at lower...”
Access document

Access document (1)
Access document (2)

“... for obesity, with the intention of weight loss and improvement in cardiovascular risk (CV risk). A good...”
Access document

“...-IR). The Akt serine phosphorylation and GLUT4 levels of microsomal (M) and plasma membrane (PM) fractions...”
Access document (1)
Access document (2)

“...We have shown that tissue-type plasminogen activator (tPA) and plasma kallikrein share a common...”
Access document

“...We have shown that tissue-type plasminogen activator (tPA) and plasma kallikrein share a common...”
Access document (1)
Access document (2)

“... AP, and after 70 days, the ME groups were treated for 30 days. Glycaemia, insulinaemia, homeostatic model...”
Access document (1)
Access document (2)

“...Etofibrate is a hybrid drug which combines niacin with clofibrate. After contact with plasma...”
Access document

Access document

“... accompanied by an increase in proinflammatory cytokines and a decrease in anti-inflammatory cytokines...”
Access document

“... or as mixtures in yoghurt (10 rats/group). After treatments, the plasma levels of glucose, triacylglycerol...”
Access document (1)
Access document (2)

“... in 2 equal meals after morning and afternoon milkings. Each experimental period consisted...”
Access document

“... for 10 weeks after which, 50% of the animals belonging to the HF group were switched to a regimen of high...”
Access document (1)
Access document (2)

“... (15 mg/Kg by gavage). BP, arterial stiffness, and plasma and tissue nitrite concentrations were assessed after the...”
Access document (1)
Access document (2)

“... (15 mg/Kg by gavage). BP, arterial stiffness, and plasma and tissue nitrite concentrations were assessed after the...”
Access document (1)
Access document (2)

“...Periodontitis is very prevalent worldwide and is one of the major causes of tooth loss in adults...”
Access document

“... interferon-β (TRIF); IFN regulatory-factor-3 (IRF-3); nuclear factor kappa-B (NF-κB); plasma concentrations...”
Access document (1)
Access document (2)

“... de intervenções: terapia rica em plaquetas plasma (PRP), células-tronco derivadas de tecido adiposo (ADSCs), ADSCs...”
Access document

Subjects: “...Plasma-mediated vapor generation...”
Access document

Subjects: “...weight loss...”
Access document (1)
Access document (2)